TITLE

BLAST screening of chlamydial genomes to identify signature proteins that are unique for the Chlamydiales, Chlamydiaceae, Chlamydophila and Chlamydia groups of species

AUTHOR(S)
Griffiths, Emma; Ventresca, Michael S; Gupta, Radhey S
PUB. DATE
January 2006
SOURCE
BMC Genomics;2006, Vol. 7, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Chlamydiae species are of much importance from a clinical viewpoint. Their diversity both in terms of their numbers as well as clinical involvement are presently believed to be significantly underestimated. The obligate intracellular nature of chlamydiae has also limited their genetic and biochemical studies. Thus, it is of importance to develop additional means for their identification and characterization. Results: We have carried out analyses of available chlamydiae genomes to identify sets of unique proteins that are either specific for all Chlamydiales genomes, or different Chlamydiaceae family members, or members of the Chlamydia and Chlamydophila genera, or those unique to Protochlamydia amoebophila, but which are not found in any other bacteria. In total, 59 Chlamydialesspecific proteins, 79 Chlamydiaceae-specific proteins, 20 proteins each that are specific for both Chlamydia and Chlamydophila and 445 ORFs that are Protochlamydia-specific were identified. Additionally, 33 cases of possible gene loss or lateral gene transfer were also detected. Conclusion: The identified chlamydiae-lineage specific proteins, many of which are highly conserved, provide novel biomarkers that should prove of much value in the diagnosis of these bacteria and in exploration of their prevalence and diversity. These conserved protein sequences (CPSs) also provide novel therapeutic targets for drugs that are specific for these bacteria. Lastly, functional studies on these chlamydiae or chlamydiae subgroup-specific proteins should lead to important insights into lineage-specific adaptations with regards to development, infectivity and pathogenicity.
ACCESSION #
28858595

 

Related Articles

  • Laboratory diagnosis of persistent human chlamydial infection. Puolakkainen, Mirja // Frontiers in Cellular & Infection Microbiology;Nov2013, Vol. 3, p1 

    Diagnostic assays for persistent chlamydial infection are much needed to conduct high-quality, large-scale studies investigating the persistent state in vivo, its disease associations and the response to therapy. Yet in most studies the distinction between acute and persistent infection is based...

  • Prevalence and diagnostic significance of specific IgA and anti-heat shock protein 60 Chlamydia trachomatis antibodies in subfertile women. Arsovic, A.; Nikolov, A.; Sazdanovic, P.; Popovic, S.; Baskic, D. // European Journal of Clinical Microbiology & Infectious Diseases;May2014, Vol. 33 Issue 5, p761 

    The objective of the present study was to evaluate the clinical usefulness of the simultaneous measurement of three serological markers of chlamydial infection in women with tubal factor infertility (TFI) and spontaneous miscarriage. Serum was collected from 87 patients (33 with TFI and 54 with...

  • Surveillance of Airborne Adenovirus and Mycoplasma pneumoniae in a Hospital Pediatric Department. Gwo-Hwa Wan; Chung-Guei Huang; Yhu-Chering Huang; Ju-Ping Huang; Su-Li Yang; Tzou- Yien Lin; Kuo-Chien Tsao // PLoS ONE;Mar2012, Vol. 7 Issue 3, p1 

    This investigation evaluated the distributions of airborne adenovirus and Mycoplasma pneumoniae in public areas in the pediatric department of Children's Hospital in northern Taiwan. The airborne viral and bacterial concentrations were evaluated twice a week for a year using filter sampling with...

  • Induction of Protective Immunity against Chlamydia muridarum Intravaginal Infection with a Chlamydial Glycogen Phosphorylase. Zhihong Li; Chunxue Lu; Bo Peng; Hao Zeng; Zhiguan Zhou; Yimou Wu; Zhong, Guangming // PLoS ONE;Mar2012, Vol. 7 Issue 3, p1 

    We evaluated 7 C. muridarum ORFs for their ability to induce protection against chlamydial infection in a mouse intravaginal infection model. These antigens, although encoded in C. muridarum genome, are transcriptionally regulated by a cryptic plasmid that is known to contribute to C. muridarum...

  • What to do about chlamydia.  // American Family Physician;6/1/1994, Vol. 49 Issue 8, p1832 

    Provides an overview of chlamydia. Symptoms; Diagnosis and treatment; Transmission; Infection during pregnancy; Prevention.

  • DoH stalls on chlamydia screening programme. Dragon, Natalie // GP: General Practitioner;10/21/2002, p18 

    Reports that the government of Great Britain is stalling on a national chlamydia screening program despite evidence of growing number of infections in the country. Development of a screening program the National Strategy for Sexual Health and HIV.

  • Chlamydia: Big problem in US.  // Dermatology Times;Dec96, Vol. 17 Issue 12, p17 

    Reports that chlamydia has been the most commonly reported infection in the United States in 1995.

  • Women and the chlamydia epidemic. Lever, Janet; Schwartz, Pepper // Glamour;Feb94, Vol. 92 Issue 2, p46 

    Gives details on chlamydia. Incidence of transmission; Diagnosis; Effect to fertility; Complications; Screening and treatment guidelines of the Centers for Disease Control and Prevention.

  • Chlamydia pneumoniae antibodies and serum lipids in Finnish men: Cross sectional study. Laurila, Aino; Bloigu, Aini // BMJ: British Medical Journal (International Edition);05/17/97, Vol. 314 Issue 7092, p1456 

    Reports on the cross sectional study on Chlamydia pneumoniae infection among men conducted in the years 1986 to 1989 in Finland. Study subjects; Changes in lipid metabolism caused by Chlamydia pneumoniae infection.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics